Bijing Mao

468 total citations
11 papers, 328 citations indexed

About

Bijing Mao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bijing Mao has authored 11 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Bijing Mao's work include Cancer-related gene regulation (5 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Bijing Mao is often cited by papers focused on Cancer-related gene regulation (5 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Bijing Mao collaborates with scholars based in China. Bijing Mao's co-authors include Ge Wang, Zhimin Zhang, He Xiao, Dong Wang, Lin Lei, Chenchen Ding, Mei Jiang, Zhimin Zhang, Qiong Li and Yuanyuan Chen and has published in prestigious journals such as PLoS ONE, Frontiers in Oncology and Journal of Gastroenterology and Hepatology.

In The Last Decade

Bijing Mao

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bijing Mao China 8 275 181 30 24 14 11 328
Canbin Lin China 11 251 0.9× 235 1.3× 18 0.6× 42 1.8× 10 0.7× 19 307
Kelin She China 9 302 1.1× 299 1.7× 26 0.9× 27 1.1× 16 1.1× 11 361
Silvia Cruz-Gil Spain 6 225 0.8× 212 1.2× 55 1.8× 51 2.1× 9 0.6× 9 331
Zijuan Wu China 10 219 0.8× 172 1.0× 40 1.3× 24 1.0× 14 1.0× 23 295
Michał Świerniak Poland 7 218 0.8× 224 1.2× 18 0.6× 14 0.6× 15 1.1× 9 337
Chengzhou Lv China 9 213 0.8× 147 0.8× 30 1.0× 26 1.1× 12 0.9× 18 304

Countries citing papers authored by Bijing Mao

Since Specialization
Citations

This map shows the geographic impact of Bijing Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bijing Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bijing Mao more than expected).

Fields of papers citing papers by Bijing Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bijing Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bijing Mao. The network helps show where Bijing Mao may publish in the future.

Co-authorship network of co-authors of Bijing Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Bijing Mao. A scholar is included among the top collaborators of Bijing Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bijing Mao. Bijing Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zou, Hongbo, et al.. (2024). Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment. 23. 2234023968–2234023968. 1 indexed citations
2.
Chen, Zhuo, Chuan Chen, Wei Guan, et al.. (2024). Prognostic effect of DNA methylation of BTG2 gene in Chinese hepatocellular carcinoma. Heliyon. 10(7). e28580–e28580. 3 indexed citations
3.
Mao, Bijing, et al.. (2022). Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy. Frontiers in Oncology. 12. 967675–967675.
4.
Liu, Yang, Hongbo Zou, Qichao Xie, et al.. (2021). Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression. BioMedical Engineering OnLine. 20(1). 67–67. 9 indexed citations
5.
6.
Jiang, Mei, Hui Zhang, Jia Luo, et al.. (2017). High expression of c‑Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma. Oncology Letters. 15(1). 931–939. 15 indexed citations
7.
Mao, Bijing & Ge Wang. (2015). MicroRNAs involved with hepatocellular carcinoma (Review). Oncology Reports. 34(6). 2811–2820. 57 indexed citations
8.
Mao, Bijing, Yafei Li, Zhimin Zhang, et al.. (2015). One-Carbon Metabolic Factors and Risk of Renal Cell Cancer: A Meta-Analysis. PLoS ONE. 10(10). e0141762–e0141762. 10 indexed citations
9.
Mao, Bijing, He Xiao, Zhimin Zhang, Dong Wang, & Ge Wang. (2015). MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells. Molecular Medicine Reports. 12(4). 4917–4924. 32 indexed citations
10.
Mao, Bijing, Zhimin Zhang, & Ge Wang. (2014). BTG2: A rising star of tumor suppressors (Review). International Journal of Oncology. 46(2). 459–464. 109 indexed citations
11.
Li, Qiong, Chenchen Ding, Chuan Chen, et al.. (2013). miR‐224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 29(4). 835–842. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Canbin Lin Breakdown of academic impact, for papers by Kelin She Breakdown of academic impact, for papers by Silvia Cruz-Gil Breakdown of academic impact, for papers by Zijuan Wu Breakdown of academic impact, for papers by Michał Świerniak Breakdown of academic impact, for papers by Chengzhou Lv
Rankless by CCL
2026